Genmab A/S Stock

Genmab A/S FCF Yield

The Free Cash Flow Yield of Genmab A/S (GMAB.CO) as of Jul 21, 2026 is 6.76 %. In the previous year, Free Cash Flow Yield was 6.48 % — a change of 4.43% (higher).

FCF Yield

6.76 %

YoY

4.43%

Last updated:

Free Cash Flow Yield of Genmab A/S is 2026 6.76 % . Free Cash Flow Yield of Genmab A/S was 2025 6.48 % . It decreases by 4.43% higher compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Free Cash Flow Yield of Genmab A/S is 6.76 % in 2026.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S